Silexion Therapeutics Ltd. (SLXN) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Silexion Therapeutics Ltd. (SLXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $280,482, listed on NASDAQ, employing roughly 11 people, carrying a beta of -0.29 to the broader market. Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. Led by Ilan Hadar, public since 2024-08-16.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for SLXN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →